Related Experiment Video
Updated: Jun 20, 2026
09:24
Application and Methodology of the Non-destructive 19F Time-domain NMR Technique to Measure the Content in Fluorine-containing Drug Products
Published on: August 22, 2017
Patient-directed medicine labeling: text differences between the United States and Spain
Ulla Connor1, Miguel F Ruiz-Garrido, William Rozycki
1Indiana Center for Intercultural Communication, Indiana University Purdue University, Indianapolis, IN 46202-5170, USA. uconnor@iupui.edu
Communication & Medicine
|September 9, 2009
Summary
Patient medication information differs between the US and Spain. Spanish drug information uses more technical terms, while US materials emphasize side effects and seeking medical advice more frequently.
Area of Science:
- Pharmacology
- Health Communication
- Comparative Health Systems
Background:
- Patient adherence to medical directions is crucial for managing chronic diseases.
- Understanding variations in patient-directed medication information is essential for improving adherence.
- This study examines written drug information provided to patients in the United States (US) and Spain.
Purpose of the Study:
- To compare written patient information for medications prescribed for chronic diseases in the US and Spain.
- To analyze the legal context of information provision in both countries.
- To identify differences in content, rhetorical features, and vocabulary.
Main Methods:
- Comparative analysis of patient-directed written information for 30 common drugs (19 cardiovascular, 11 endocrine) in the US and Spain.
- Inclusion of texts in an electronic corpus for analysis.
- Identification of rhetorical features and lexical analysis.
Main Results:
- Differences were observed in the placement of information regarding 'side effects' and 'the need to seek medical advice,' appearing more frequently throughout US texts.
- Spanish texts exhibited a higher prevalence of technical vocabulary.
- Legal contexts varied, with voluntary provision in the US and mandatory provision in Spain.
Conclusions:
- Written medication information for chronic diseases shows significant differences between the US and Spain in terms of content emphasis and linguistic complexity.
- These variations may impact patient understanding and adherence.
- Further research is needed to explore the implications of these differences on patient outcomes.
Related Concept Videos
01:17Drug Nomenclature
During the development of a new pharmaceutical, the manufacturer initially assigns a code name to the drug. Once approved, the drug receives a United States Adopted Name (USAN)—a generic, nonproprietary designation. Upon being listed in the United States Pharmacopeia, this nonproprietary name becomes the drug's official name. Additionally, the manufacturer assigns a proprietary name or trademark, which serves as the brand name under which the drug is marketed. It is worth noting that the same...
01:28Drug Products: Biologics, Biosimilars and Interchangeables
Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
01:26FDA Approved Drugs: Changes to Approved Drugs
Post-approval, manufacturers may modify an approved new or generic drug product. Such modifications can encompass alterations in the Active Pharmaceutical Ingredient (API), manufacturing process, formulation, batch size, manufacturing site, and container closure system (FDA Guidance for Industry, April 2004). Often, a drug product may undergo multiple changes.These modifications require careful evaluation to determine their potential impact on the drug product's identity, strength, quality,...
01:24Dosage Regimen: Individualization
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
01:18Formulation and Manufacturing Process: Physical Attributes of Generic Tablets and Capsules
Bioequivalence in generic drugs, such as tablets and capsules, refers to their pharmaceutical equivalence to the brand-name counterparts. However, for therapeutic equivalence, manufacturers must also consider physical attributes like size, shape, and weight (FDA Guidance for Industry, December 2003). Discrepancies in these aspects could impact patient compliance and cause medication errors. For instance, swallowing difficulties, often experienced with larger tablets or capsules, can lead to...
01:02Prescription, Nonprescription and Orphan Drugs
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...